Transplantation of Fibroblast for Correction of Nasolabial Folds

Status Not yet recruiting

Clinical Trial Summary

The study evaluated the safety and efficacy of the Autologous cultured fibroblast for correction of Nasolabial folds and inhibition of skin aging

Clinical Trial Description

Autologous cultured fibroblast which is obtain from the patient's normal skin is harvested and expanded in an in vitro. Biopsies samples are obtained from the behind of the patient's ear as a source of fibroblasts, then fibroblast cells isolated and expanded through cell culture, and used for the correction of Nasolabial folds, deep wrinkles of the forehead. Prior to final packaging, cell viability is assessed to be at least 85% ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03140319
Study type	Interventional
Source	SCARM Institute, Tabriz, Iran
Contact	Peyman Keyhanvar, MD, Ph.D
Phone	0914 114 6863
Email	drkeyhanvar@gmail.com
Status	Not yet recruiting
Phase	Phase 1/Phase 2
Start date	December 10, 2020
Completion date	December 26, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04276753` - A Randomized, Double-blinded, Placebo Controlled, Monocentric Study to Evaluate the Anti-ageing and Skin Brightening Benefit of the Test Product in Healthy Female Subjects	N/A
Completed	`NCT06125912` - A Comparative Split-Face Study of the Effects of a Retinol Alternative Cream on Improving Facial Skin Aging	N/A
Completed	`NCT02580370` - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines	Phase 3
Recruiting	`NCT01583478` - Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids	Phase 4
Completed	`NCT02003833` - Poly-L-lactic Acid for Skin Quality	Phase 4
Completed	`NCT01447342` - A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines	Phase 2/Phase 3
Completed	`NCT00986570` - Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face	Phase 3
Completed	`NCT00974480` - Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging	N/A
Completed	`NCT00272610` - Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin	Phase 2
Recruiting	`NCT03730649` - Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure	Early Phase 1
Completed	`NCT03312543` - Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles	N/A
Active, not recruiting	`NCT05349799` - TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines	N/A
Completed	`NCT03677258` - Effectiveness and Safety of Collagen Complex COLLOST in Anti-age Therapy	N/A
Withdrawn	`NCT05854628` - The Role of Red Flavonoid in Photoaging	N/A
Completed	`NCT01981980` - Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation	N/A
Not yet recruiting	`NCT00767156` - Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging	N/A
Recruiting	`NCT05813054` - Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®	N/A
Not yet recruiting	`NCT04485091` - TCA Peel and Photobiomodulation for Hand Rejuvenation	Phase 2
Completed	`NCT05457491` - Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)	Phase 1
Completed	`NCT01237977` - Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines	Phase 3